With the development of cell biology and microbiology, it has become easy to culture many types of animal cells and microbes, and they are frequently used for phenotypic screening to explore medicinal seeds. On the other hand, it is recognized that cells and pathogenic microbes present in pathologic sites and infected regions of the human body display unique properties diŠerent from those under general culture conditions. We isolated several bioactive compounds from marine medicinal resources using constructed bioassay-guided separation focusing on the unique changes in the characteristics of cells and pathogenic microbes (Mycobacterium spp.) in the human body under disease conditions. In addition, we also carried out identiˆcation studies of target molecules of the bioactive compounds by methods utilizing the gene expression proˆle, transformants of cells or microbes, synthetic probe molecules of the isolated compounds, etc., since bioactive compounds isolated from the phenotypic screening system often target new molecules. This review presents our phenotypic screening systems, isolation of bioactive compounds from marine medicinal resources, and target identiˆcation of bioactive compounds.
(B and C) Each strain [Strain S1 Strain S10 (B, over-expressing each S1 S10 area), S_BCG3184c S_BCG3187c (C, over-expressing each BCG3184c BCG3187c), wild-type of M. smegmatis and Strain 2] was cultured in the 7H9 broth, and then the cultures were adjusted to 1×10 5 CFU/mL. The 10 mL aliquots of each culture were spread on the 7H10 agar plate in the presence or absence of agelasine D (1.6 mg/mL). 
